January 2002 newsletter
 

 

Goal and Objectives

Our goal is to mobilize public support for cancer research so that we can accelerate the nation’s progress toward the prevention and cure of cancer. Toward that end, our objectives are to:

  • Demonstrate the benefits of cancer research;
  • Illustrate the need for answers to this terrible disease; and
  • Explain the investment needed for the task ahead.

 

A. FY03 Budget Update

Friends of Cancer Research once again applauds President Bush for his strong support of the National Institutes of Health by proposing a continuation of the doubling effort. Having lost his sister to leukemia at an early age, the President intimately understands how necessary innovative research is and the hope it provides people of all ages who are suffering from debilitating diseases. His advocacy is critical and greatly appreciated.

 

 

B.

Congressional Support

The FY03 federal budget may be the tightest in years as the government returns to deficit spending. Programs hardest hit will be those that fall into the domestic discretionary area. This means that as advocates for an increase in the NIH budget, we must be aggressive and strategic in our advocacy as we compete with a broad range of interests reaching for shrinking funds.

In FY02, the Congress continued on the doubling path by providing $23.285 billion for the NIH, of which the National Cancer Institute is receiving $4.19 billion. Friends will continue its aggressive education campaign both inside and outside the beltway to ensure that Members who play a significant role in determining the budget numbers understand how the valuable federal dollars appropriated in the past four budget cycles have been invested. The "doubling effort" was not only the right political decision but, more importantly, a decision based on sound science.

 

 

C. Town Hall Meetings

As we have done in years past, Friends, with the participation of its distinguished board, will conduct outreach to policymakers and opinion leaders about the growing needs of the cancer research community. We will pursue high-level meetings with senior officials in the Administration and on Capitol Hill. We will also be taking our education campaign on the road to visit some of the nation’s premier cancer institutes where we will be conducting town hall meetings. The schedule for these events will be provided once the sites have been identified.

 

 
Ellen Sigal Marlene Malek   Beth Mendelson
Chair President  Executive Director